New patent for Pharmacyclics Inc drug IMBRUVICA

August 16, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are forty patents…

The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.